Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.23.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenue $ 0 $ 0 $ 0 $ 0
Costs and Operating Expenses        
Cost of revenue, excluding depreciation 0 0 0 0
Research and development expenses, excluding depreciation 38,582 115,460 85,686 197,946
Selling, general and administrative expenses, excluding depreciation 30,421 55,152 60,270 110,773
Depreciation 4,562 2,892 9,137 5,570
Total costs and operating expenses 73,565 173,504 155,093 314,289
Loss from operations (73,565) (173,504) (155,093) (314,289)
Other (expense) income        
Interest (expense) income (2,264) 19 (2,560) (9)
Gain on fair value change in contingent earnout shares liability 59 9,471 2,564 24,936
Gain on fair value change in warrant and derivative liability 5,623 0 22,965 0
Loss on extinguishment of debt (949) 0 (27,688) 0
Other income (expense), net 226 (378) (1,790) (395)
Loss before income taxes (70,870) (164,392) (161,602) (289,757)
Provision for income taxes 0 0 0 0
Net loss and comprehensive loss (70,870) (164,392) (161,602) (289,757)
Net loss and comprehensive loss $ (70,870) $ (164,392) $ (161,602) $ (289,757)
Per Share Data:        
Net loss per share, basic (in dollars per share) $ (0.14) $ (0.68) $ (0.35) $ (1.22)
Net loss per share, diluted (in dollars per share) $ (0.14) $ (0.68) $ (0.35) $ (1.22)
Weighted-average shares outstanding, basic (in shares) 505,576 242,772 462,303 238,242
Weighted-average shares outstanding, diluted (in shares) 505,576 242,772 462,303 238,242